Editas Medicine, Inc.
EDIT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650664
In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Editas Medicine, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 5 filings
- 3 insiders, $34.0K in total
- Insiders trading
- 3
- Net value
- −$34.0K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Editas Medicine, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ory Daniel Scott | EVP, Chief Medical Officer | – | Sep 9, 2026 | 1 |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | 61,660 | Sep 4, 2026 | 6 |
| Parison Amy | SVP, Chief Financial Officer | 13,839 | Sep 4, 2026 | 6 |
| O'Neill Gilmore Neil | CEO | 243,189 | Sep 4, 2026 | 5 |
| Ellinor Patrick Thomas II | Director | – | Aug 7, 2026 | 1 |
| Hirsch Andrew | Director | – | Jun 22, 2026 | 1 |
| Hopfield Jessica | Director | 67,700 | Jun 22, 2026 | 1 |
| Connaughton Bernadette | Director | – | Jun 22, 2026 | 1 |
| Scadden David | Director | – | Jun 22, 2026 | 1 |
| Levy Elliott M. | Director | – | Jun 22, 2026 | 1 |
| Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | 112,720 | Mar 27, 2025 | 0 |
| Mei Baisong | EVP, CHIEF MEDICAL OFFICER | 133,354 | Dec 5, 2024 | 0 |
| Vaishnaw Akshay | Director | – | Jun 3, 2024 | 0 |
| Reeve Emma | Director | – | Jun 3, 2024 | 0 |
| Chatterjee Meeta | Director | – | Jun 3, 2024 | 0 |
| Eaton Bruce | EVP, CBO AND CTO | 74,791 | Dec 7, 2023 | 0 |
| Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | 106,610 | May 15, 2023 | 0 |
| Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | 65,559 | Feb 15, 2023 | 0 |
| Mullen James C | CEO | 75,898 | Apr 18, 2022 | 0 |
| Michaels Lisa Anne | EVP/Chief Medical Officer | 22,675 | Dec 23, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 (view filing) | Mar 3 | 3 days | Eaton BruceEVP, CBO AND CTO | SSale | −101 | $8.89 | −$897.89 | −0.1%77.6K after | |
| Feb 15, 2023 (view filing) | Feb 13 | 2 days | Shearman Mark SEVP, CHIEF SCIENTIFIC OFFICER | SSale | −2.79K | $9.67 | −$27.0K | −4.1%65.6K after | |
| Feb 15, 2023 (view filing) | Feb 13 | 2 days | Robertson MichelleEVP, CHIEF FINANCIAL OFFICER | SSale | −4.29K | $9.67 | −$41.5K | −5.3%76.2K after | |
| Feb 15, 2023 (view filing) | Feb 13 | 2 days | Eaton BruceEVP, CBO AND CTO | SSale | −3.31K | $9.67 | −$32.0K | −5.1%61.0K after | |
| Feb 9, 2023 (view filing) | Feb 7 | 2 days | Eaton BruceEVP, CBO AND CTO | SSale | −346 | $11.10 | −$3.84K | −0.5%64.3K after | |
| Jan 12, 2023 (view filing) | Jan 10 | 2 days | Robertson MichelleEVP, CHIEF FINANCIAL OFFICER | SSale | −1.75K | $8.16 | −$14.3K | −2.1%80.5K after | |
| Dec 6, 2022 (view filing) | Dec 5 | 1 day | Robertson MichelleEVP, CHIEF FINANCIAL OFFICER | SSale | −193 | $10.23 | −$1.97K | −0.2%82.3K after | |
| Dec 6, 2022 (view filing) | Dec 5 | 1 day | Eaton BruceEVP, CHIEF BUSINESS OFFICER | SSale | −102 | $10.23 | −$1.04K | −0.2%64.6K after | |
| Nov 9, 2022 (view filing) | Nov 8 | 1 day | Eaton BruceEVP, CHIEF BUSINESS OFFICER | SSale | −289 | $11.02 | −$3.18K | −0.4%64.7K after | |
| Sep 8, 2022 (view filing) | Sep 6 | 2 days | Robertson MichelleEVP, CHIEF FINANCIAL OFFICER | SSale | −192 | $15.01 | −$2.88K | −0.2%82.5K after | |
| Sep 8, 2022 (view filing) | Sep 6 | 2 days | Eaton BruceEVP, CHIEF BUSINESS OFFICER | SSale | −101 | $15.01 | −$1.52K | −0.2%65.0K after | |
| Aug 10, 2022 (view filing) | Aug 9 | 1 day | Eaton BruceEVP, CHIEF BUSINESS OFFICER | SSale | −293 | $18.60 | −$5.45K | −0.4%65.1K after | |
| Jun 16, 2022 (view filing) | Jun 15 | 1 day | Shearman Mark SEVP, CHIEF SCIENTIFIC OFFICER | SSale | −5.14K | $10.06 | −$51.8K | −7.0%68.3K after | |
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Eaton BruceEVP, CHIEF BUSINESS OFFICER | SSale | −1.12K | $11.54 | −$13.0K | −1.7%65.4K after | |
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Robertson MichelleEVP, CHIEF FINANCIAL OFFICER | SSale | −1.53K | $11.54 | −$17.6K | −1.8%82.7K after | |
| May 11, 2022 (view filing) | May 9 | 2 days | Eaton BruceEVP, CHIEF BUSINESS OFFICER | SSale | −297 | $13.11 | −$3.89K | −0.4%66.5K after | |
| Apr 4, 2022 (view filing) | Aug 9, 2021-Apr 1, 2022 | 238 daysLate | Eaton BruceEVP, CHIEF BUSINESS OFFICER | SSale | −1.54K | $26.61 | −$41.1K | −2.3%66.8K after | 2 lots |
| Mar 7, 2022 (view filing) | Mar 3 | 4 days | Eaton BruceEVP, CHIEF BUSINESS OFFICER | SSale | −403 | $17.33 | −$6.98K | −0.6%68.4K after | |
| Mar 7, 2022 (view filing) | Mar 3 | 4 days | Robertson MichelleEVP, CHIEF FINANCIAL OFFICER | SSale | −767 | $17.33 | −$13.3K | −0.9%84.2K after | |
| Feb 10, 2022 (view filing) | Feb 8 | 2 days | Eaton BruceEVP, CHIEF BUSINESS OFFICER | SSale | −302 | $17.63 | −$5.32K | −1.0%31.2K after | |
| Jan 13, 2022 (view filing) | Jan 11 | 2 days | Robertson MichelleChief Financial Officer | SSale | −1.74K | $25.70 | −$44.8K | −5.3%31.5K after | |
| Jan 4, 2022 (view filing) | Jan 3 | 1 day | Mullen James CCEO | SSale | −18.3K | $26.95 | −$491.9K | −19.4%75.9K after | |
| Nov 15, 2021 (view filing) | Nov 12 | 3 days | Michaels Lisa AnneEVP/Chief Medical Officer | SSale | −1.57K | $38.33 | −$60.1K | −7.8%18.4K after | |
| Nov 10, 2021 (view filing) | Nov 9 | 1 day | Eaton BruceEVP, Chief Business Officer | SSale | −287 | $40.61 | −$11.7K | −1.0%28.0K after | |
| Oct 20, 2021 (view filing) | Oct 18 | 2 days | Mullen James CCEO | SSale | −13.8K | $38.03 | −$525.0K | −19.3%57.7K after | |
| Aug 10, 2021 (view filing) | Aug 9 | 1 day | Robertson MichelleChief Financial Officer | SSale | −2.50K | $60.00 | −$150.0K | −8.0%28.7K after |